For research use only. Not for therapeutic Use.
Lucidenic acid B (CAT: I018378) is a bioactive compound belonging to the triterpenoid family, primarily found in the fruiting bodies of the medicinal mushroom Ganoderma lucidum (Reishi). It possesses various pharmacological activities and has been studied for its potential health benefits. Lucidenic acid B exhibits antioxidant properties, helping to neutralize harmful free radicals and protect cells from oxidative damage. It also shows anti-inflammatory effects by inhibiting pro-inflammatory signaling pathways. Moreover, lucidenic acid B has demonstrated immunomodulatory activity, enhancing the activity of immune cells and supporting immune function. It has also been investigated for its potential anticancer properties, showing promising results in inhibiting cancer cell growth and inducing apoptosis.
Catalog Number | I018378 |
CAS Number | 95311-95-8 |
Molecular Formula | C₂₇H₃₈O₇ |
Purity | ≥95% |
Target | Apoptosis |
Reference | [1]. Hsu CL, et al. Lucidenic acid B induces apoptosis in human leukemia cells via a mitochondria-mediated pathway. J Agric Food Chem. 2008 Jun 11;56(11):3973-80. |